50242-0105
POLIVY
polatuzumab vedotin
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Intravenous
POLATUZUMAB VEDOTIN
140.0
mg/7.52mL
50242-0105-01
1 VIAL, SINGLE-DOSE in 1 CARTON (50242-105-01) > 20 mL in 1 VIAL, SINGLE-DOSE
June 10, 2019
Immunotherapy
Drug Antibody Conjugate
CD79b
 
In Use